rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCCTCGGGACGGGGAACACTGAAGCTTTCTTTGGACAA	CASTLGTGNTEAFF	In	VDJ	1	11	0.0011020939785592627	0.0013079667063020215	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	6	0	7	1	5	3	23	33	43	38	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASTLGTGNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCGGGACAGGTTACCCCGTCTGCAGCTTTCTTTGGACAA	CASSSGQVTPSAAFF	In	VDJ	1	12	0.0012022843402464682	0.001426872770511296	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	4	10	2	13	23	35	45	37	58			01,02										Vb 1	CASSSGQVTPSAAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGACCGGGAGAAGAGACCCAGTACTTCGGGCCA	CASSVGPGEETQYF	In	VDJ	1	22	0.0022041879571185253	0.002615933412604043	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	8	2	3	3	0	23	39	-1	42	48			01,02										Vb 1	CASSVGPGEETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*02	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCAACTACGGAGTCCTTGGGACCCAGTACTTCGGGCCA	CASSSNYGVLGTQYF	In	VDJ	1	29	0.002905520488928965	0.0034482758620689655	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	3	9	7	4	12	23	35	43	39	55			01,02			01,02							Vb 1	CASSSNYGVLGTQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGAACTAGCAATGAGCAGTTCTTCGGGCCA	CASSGTSNEQFF	In	VDJ	1	34	0.0034064722973649935	0.004042806183115339	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	8	6	2	0	23	36	-1	38	43			01,02			01,02							Vb 1	CASSGTSNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSQGLNTEAFF	In	VDJ	1	13	0.001302474701933674	0.0015457788347205707	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	9	0	0	0	0	29	-1	-1	45	48													Vb 16	CASSQGLNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATGGAGGACAGAAGAGACCCAGTACTTCGGGCCA	CASSQWRTEETQYF	In	VDJ	1	14	0.0014026650636208796	0.0016646848989298453	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	1	5	3	4	0	29	44	-1	48	54													Vb 16	CASSQWRTEETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGCGGTTAGGGGAGCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	19	0.0019036168720569081		50	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	0	5	2	17	7	19	29	46	58	53	77				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGAGGACAGGGGTTTGAAGCTTTCTTTGGACAA	CASSRGQGFEAFF	In	VDJ	1	20	0.0020038072337441137	0.0023781212841854932	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	2	7	2	2	29	42	53	44	55													Vb 16	CASSRGQGFEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCCTACAGGGGGGCTCACGAGCAGTACGTCGGGCCG		Out	VDJ	1	41	0.004107804829175434		41	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	1	17	4	16	29	40	52	44	68													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACTGGGAAGATACAATGAGCAGTTCTTCGGGCCA	CASSQLGRYNEQFF	In	VDJ	2	74	0.007414086764853221	0.008799048751486327	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	2	0	8	4	2	3	29	44	50	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQLGRYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAACAGAGATGGCTGAAGCTTTCTTTGGACAA	CASSLTEMAEAFF	In	VDJ	3	82	0.008215609658350867	0.009750297265160524	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	5	6	2	6	29	42	48	44	54													Vb 16	CASSLTEMAEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGACACAGGTTGAGTAATTCACCCCTCCACTTTGGGAAC	CASRHRLSNSPLHF	In	VDJ	1	9	9.017132551848512E-4	0.001070154577883472	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	4	6	2	5	24	35	42	37	47														CASRHRLSNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTGGACAGTAATCAGCCCCAGCATTTTGGTGAT	CASSLDSNQPQHF	In	VDJ	1	11	0.0011020939785592627	0.0013079667063020215	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	4	3	1	24	35	44	38	45														CASSLDSNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAATCATCAGGGGGCAGACTATGGCTACACCTTCGGTTCG	CASNHQGADYGYTF	In	VDJ	1	12	0.0012022843402464682	0.001426872770511296	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	4	0	3	8	2	24	31	47	39	49														CASNHQGADYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTCTTAAACAGGGCGCCAACTGTTTTTTGGCAGT	CASSS*TGRQLFF	Stop	VDJ	1	12	0.0012022843402464682		39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	12	7	4	24	35	48	42	52														CASSS*TGRQLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGCTGCGGAGACTAGTACAGATACGCAGTATTTTGGCCCA	CASAAETSTDTQYF	In	VDJ	1	13	0.001302474701933674	0.0015457788347205707	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	2	8	3	10	1	24	31	47	41	48						01,02								CASAAETSTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCACGGTTCCCGGGGAGCTGTTTTTTGGAGAA	CASSPTVPGELFF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	5	6	4	3	24	36	43	40	46						01,02								CASSPTVPGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAATGTACGGAAGGCCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASRMYGRPE*KTYGYTF	Stop	VDJ	1	28	0.002805330127241759		54	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	1	8	4	7	17	24	35	45	42	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRMYGRPE*KTYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAGCCCCGCCAGGGTCGTGAGCTGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSKPRQGRELGNQPQHF	In	VDJ	1	29	0.002905520488928965	0.0034482758620689655	57	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	2	7	11	24	38	50	45	61														CASSKPRQGRELGNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAAAGGAGGGGGTGGCAAGAGACCCAGTACTTCGGGCCA	CASSERRGWQETQYF	In	VDJ	1	31	0.0031059012123033766	0.0036860879904875147	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	6	5	1	2	7	3	24	35	48	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERRGWQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACCCGAGCGGGGGGCCGCTCTAGCACAGATACGCAGTATTTTGGCCCA	CASTRAGGRSSTDTQYF	In	VDJ	1	41	0.004107804829175434	0.004875148632580262	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	6	1	0	7	7	24	31	47	38	54														CASTRAGGRSSTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAACCCCTCGGCAGGCGGGGGGCCTGGATGAGCAGTTCTTCGGGCCA	CASSVTPRQAGGLDEQFF	In	VDJ	1	42	0.004207995190862639	0.004994054696789536	54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	1	8	15	5	24	36	59	51	64														CASSVTPRQAGGLDEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGATGGGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSVDGGGETQYF	In	VDJ	1	43	0.004308185552549844	0.005112960760998811	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	1	4	8	0	24	36	-1	44	50														CASSVDGGGETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCGAGGGGGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSPEGGMNTEAFF	In	VDJ	2	50	0.0050095180843602845	0.005945303210463734	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	0	5	1	24	36	48	41	49														CASSPEGGMNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTACCCTGATGGGGTCAAGACTCCTACGAGCAGTACGTCGGGCCG	CASSLP*WGQDSYEQYV	Stop	VDJ	4	127	0.012724175934275123		51	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-07	01	2	6	2	17	7	23	18	33	44	40	67				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLP*WGQDSYEQYV+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01		TCRBJ02-07*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCGGACAGGATAGCAGCAGCAGCCCCAGCATTTTGGTGAT	CASSRTG*QQQPQHF	Stop	VDJ	1	29	0.002905520488928965		45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	4	7	1	10	19	31	39	32	49														CASSRTG*QQQPQHF+TCRBV07-05+TCRBJ01-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGCAGCTTATCGGGGGGCTGTCGAGGCTTTCTTTGGACAA		Out	VDJ	1	10	0.0010019036168720569		47	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	1	11	9	8	26	40	56	49	64			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCACCTGACAGCTCTGGAAACACCATATATTTTGGAGAG	CASPDSSGNTIYF	In	VDJ	1	17	0.0017032361486824968	0.0020214030915576696	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	2	5	0	5	0	26	33	-1	38	43													Vb 20	CASPDSSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCACCAGGACAGATTCTACAATGAGCAGTTCTTCGGGCCA	CAWHQDRFYNEQFF	In	VDJ	1	18	0.0018034265103697023	0.002140309155766944	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	5	3	5	3	26	35	46	40	49													Vb 20	CAWHQDRFYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCTTCGACGGTCTTGGGGGGTATACGCAGTATTTTGGCCCA	CAWSFDGLGGYTQYF	In	VDJ	1	29	0.002905520488928965	0.0034482758620689655	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	1	7	13	1	26	37	56	50	57			unresolved										Vb 20	CAWSFDGLGGYTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGCTGGCAATCAGCCCCAGCATTTTGGTGAT	CAWSVAGNQPQHF	In	VDJ	1	41	0.004107804829175434	0.004875148632580262	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	0	10	0	2	1	2	26	40	43	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVAGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGTCTCCGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSVVSGSNQPQHF	In	VDJ	2	60	0.006011421701232342	0.007134363852556481	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	8	4	1	6	0	26	40	-1	46	50			unresolved			01,02							Vb 20	CAWSVVSGSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGTACAGGGAAAACACTGAAGCTTTCTTTGGACAA	CASSQGYRENTEAFF	In	VDJ	1	19	0.0019036168720569081	0.002259215219976219	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	3	2	3	2	23	39	48	42	50														CASSQGYRENTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTCGTACTGACAGATACGCAGTATTTTGGCCCA	CASSQVVLTDTQYF	In	VDJ	1	23	0.002304378318805731	0.0027348394768133173	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	3	10	3	4	1	23	39	46	43	47						01,02								CASSQVVLTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCATCGAAGTAGCGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSHRSSGTSTDTQYF	In	VDJ	10	309	0.03095882176134656	0.036741973840665874	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	3	0	6	2	23	37	51	43	53														CASSHRSSGTSTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTTCGGTACAGGGGGCATATGGCTACACCTTCGGTTCG	CASSSVQGAYGYTF	In	VDJ	1	14	0.0014026650636208796	0.0016646848989298453	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	0	5	6	1	19	30	45	36	46													Vb 5.1	CASSSVQGAYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTCCGCTAGCGCCAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	19	0.0019036168720569081		50	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	4	6	0	4	2	19	35	45	39	47						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD02-01	TCRBJ02-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAAGTAACAGGCGGTACACTGAAGCTTTCTTTGGACAA	CASSQSNRRYTEAFF	In	VDJ	1	29	0.002905520488928965	0.0034482758620689655	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	4	3	7	4	19	31	43	38	47													Vb 5.1	CASSQSNRRYTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGTCAAGCCCCGGGCGGACGGAACTATGGCTACACCTTCGGTTCG	YASSQAPGGRNYGYTF	In	VDJ	1	21	0.0021039975954313195	0.002497027348394768	48	TCRBV17	TCRBV17-01	01				TCRBJ01	TCRBJ01-02	01	11	1	7	2	21	2	22	25	50	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									YASSQAPGGRNYGYTF+TCRBV17-01+TCRBJ01-02	TCRBV17-01*01		TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTTCCGGACAAATGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	0.002304378318805731		44	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	6	4	3	4	18	32	40	35	44														X+TCRBV12-02+TCRBJ01-05	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTCCGGACAGGCCAACGTCCTGACTTTCGGGGCC	CASSSGQANVLTF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	6	6	1	0	22	36	-1	37	42														CASSSGQANVLTF+TCRBV07-01+TCRBJ02-06	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGCAGGGGGTCGGCAATGAGCAGTTCTTCGGGCCA	CASSGQGVGNEQFF	In	VDJ	1	9	9.017132551848512E-4	0.001070154577883472	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	1	6	2	4	23	36	45	38	49													Vb 12	CASSGQGVGNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAGCGGGTGGGCAGGGAAACATTCAGTACTTCGGCGCC	CASSEAGGQGNIQYF	In	VDJ	1	11	0.0011020939785592627	0.0013079667063020215	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	6	4	6	0	9	23	-1	43	37	52						01,02							Vb 12	CASSEAGGQGNIQYF+TCRBV10-02+TCRBJ02-04	TCRBV10-02*01	TCRBD02-01	TCRBJ02-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTTGGAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSELEGNTEAFF	In	VDJ	1	30	0.003005710850616171	0.0035671819262782403	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	10	0	1	1	0	23	39	-1	40	46													Vb 12	CASSELEGNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGAGGGAGGGAACGACCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	62	0.006211802424606753		46	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	10	0	1	0	6	23	-1	44	38	50													Vb 12	X+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGGGGCAAACTCCCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	0.0014026650636208796		46	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	8	0	1	0	9	24	-1	41	37	50													Vb 12	X+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGGACAGCTTCTACAATGAGCAGTTCTTCGGGCCA	CASSEDSFYNEQFF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	5	3	0	3	24	-1	44	39	47													Vb 12	CASSEDSFYNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCTTACCCATCCAGGGATAGAGGCCACGAGCAGTACGTCGGGCCG		Out	VDJ	1	16	0.001603045786995291		46	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	4	3	17	11	21	24	31	47	42	68													Vb 12	X+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGCCCGGGGAGGGTAACACTGAAGCTTTCTTTGGACAA	CAISEPGEGNTEAFF	In	VDJ	1	21	0.0021039975954313195	0.002497027348394768	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	0	2	4	1	23	38	49	42	50													Vb 12	CAISEPGEGNTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01*02	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCCGGGGAGCATCAGCCCCAGCATTTTGGTGAT	CASSIPGEHQPQHF	In	VDJ	1	10	0.0010019036168720569	0.0011890606420927466	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	8	3	5	3	3	27	41	49	44	52			01,02			01,02							Vb 17	CASSIPGEHQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCAAGGGGGCCCGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGGPSSGANVLTF	In	VDJ	1	12	0.0012022843402464682	0.001426872770511296	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	5	0	0	3	5	27	38	48	41	53			01,02										Vb 17	CASSQGGPSSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAGGGGAGCCGAGACAGGGTAGGTACGAGCAGTACGTCGGGCCG	CASKGEPRQGRYEQYV	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	3	17	12	17	27	37	56	49	73			01,02										Vb 17	CASKGEPRQGRYEQYV+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTCTCACAACCTACACCTTCGGTTCG	CASSIGLTTYTF	In	VDJ	1	17	0.0017032361486824968	0.0020214030915576696	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	6	10	5	2	27	43	51	48	53			01,02										Vb 17	CASSIGLTTYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGTCCGACGGGGACCTATGGCTACACCTTCGGTTCG	CASSISPTGTYGYTF	In	VDJ	1	18	0.0018034265103697023	0.002140309155766944	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	0	7	4	10	0	27	41	-1	51	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISPTGTYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACTAGCGGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSITSGGSTDTQYF	In	VDJ	1	20	0.0020038072337441137	0.0023781212841854932	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	3	2	0	0	1	27	-1	53	42	54			01,02										Vb 17	CASSITSGGSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGTTAGGGCCCTACACCTTCGGTTCG	CASSMGLGPYTF	In	VDJ	1	20	0.0020038072337441137	0.0023781212841854932	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	5	3	10	6	2	27	41	51	47	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGLGPYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGACAGGGGGCGATCCACCGGGGAGCTGTTTTTTGGAGAA	CASSDRGRSTGELFF	In	VDJ	1	21	0.0021039975954313195	0.002497027348394768	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	0	4	1	4	27	38	49	39	53			01,02										Vb 17	CASSDRGRSTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTATGGGGACCAAGAGACCCAGTACTTCGGGCCA	CASSIYGDQETQYF	In	VDJ	1	25	0.0025047590421801423	0.002972651605231867	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	6	2	0	4	0	27	41	-1	45	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIYGDQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCATTGAGTGAAAAACTGTTTTTTGGCAGT	CASSPLSEKLFF	In	VDJ	1	37	0.0037070433824266105	0.004399524375743163	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	11	2	7	5	0	27	39	-1	44	47			01,02										Vb 17	CASSPLSEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCAGACAGGGGGCTTGTTGAAAAACTGTTTTTTGGCAGT	CASSSDRGLVEKLFF	In	VDJ	1	37	0.0037070433824266105	0.004399524375743163	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	0	7	3	4	27	39	52	42	56			01,02										Vb 17	CASSSDRGLVEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGGGCCCTAAATCAGCCCCAGCATTTTGGTGAT	CASRALNQPQHF	In	VDJ	1	37	0.0037070433824266105	0.004399524375743163	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	8	8	0	4	1	4	27	36	41	37	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRALNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACCATGGGGGGTTGGAGCACAGATACGCAGTATTTTGGCCCA	CASSTMGGWSTDTQYF	In	VDJ	1	44	0.004408375914237051	0.005231866825208086	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	9	1	0	6	4	27	38	50	44	54			01,02										Vb 17	CASSTMGGWSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCTGACCAGTTCTACTGAAGCTTTCTTTGGACAA	CASSILTSSTEAFF	In	VDJ	2	47	0.0047089469992986676	0.00558858501783591	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	2	7	5	3	7	27	41	47	44	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSILTSSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAATATGTTTCGTACAGTCTTCACAGATACGCAGTATTTTGGCCCA	CANMFRTVFTDTQYF	In	VDJ	2	51	0.00510970844604749	0.006064209274673008	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	3	5	2	11	4	27	34	49	45	53			01,02										Vb 17	CANMFRTVFTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGACACGGGTGAAAAACTGTTTTTTGGCAGT	CASSIDTGEKLFF	In	VDJ	2	51	0.00510970844604749	0.006064209274673008	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	3	2	6	7	1	4	27	41	46	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDTGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCAGGGGGCCGATATGGCTACACCTTCGGTTCG	CASSIPGGRYGYTF	In	VDJ	2	52	0.005209898807734696	0.006183115338882283	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	0	5	1	3	27	42	51	43	54			01,02										Vb 17	CASSIPGGRYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAGTCCGAGGGTCGGCGGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	54	0.005410279531109108		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	0	7	6	7	27	39	50	45	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACCCGGCGGGACAGTTAAGCACTGAAGCTTTCTTTGGACAA	CASNPAGQLSTEAFF	In	VDJ	2	60	0.006011421701232342	0.007134363852556481	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	4	7	5	27	37	51	44	56			01,02										Vb 17	CASNPAGQLSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGACTAGCGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASSMTSGGYNEQFF	In	VDJ	2	67	0.006712754233042782	0.007966706302021403	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	2	2	4	0	1	27	-1	53	41	54			01,02										Vb 17	CASSMTSGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGAGGGAAGGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	68	0.006812944594729987		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	0	5	1	5	27	39	45	40	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGACTAGCAACCCACAAGAGACCCAGTACTTCGGGCCA	CASSTTSNPQETQYF	In	VDJ	2	74	0.007414086764853221	0.008799048751486327	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	2	7	2	1	6	27	40	48	41	54			01,02			01,02							Vb 17	CASSTTSNPQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGACTGAATGAGCAGTTCTTCGGGCCA	CASSIGLNEQFF	In	VDJ	2	75	0.007514277126540427	0.0089179548156956	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	10	7	0	1	27	-1	47	43	48			01,02			01,02							Vb 17	CASSIGLNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGACTCTCACAGCAGTTCTTCGGGCCA	CASSMGLSQQFF	In	VDJ	3	78	0.007814848211602044	0.009274673008323424	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	11	0	5	27	-1	47	41	52			01,02			01,02							Vb 17	CASSMGLSQQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAAGACCGGGAGCTACGAGCAGTACGTCGGGCCG	CASRKTGSYEQYV	In	VDJ	3	79	0.00791503857328925	0.0093935790725327	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	2	17	6	14	27	38	50	44	64			01,02										Vb 17	CASRKTGSYEQYV+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTAGGGGTTGCTCAGCCCCAGCATTTTGGTGAT	CASSVGVAQPQHF	In	VDJ	3	99	0.009918845807033363	0.011771700356718193	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	1	0	9	6	0	4	27	-1	46	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVGVAQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAACCCGTACTGGAAACACCATATATTTTGGAGAG	CASRTRTGNTIYF	In	VDJ	4	111	0.011121130147279832	0.013198573127229489	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	6	3	7	2	1	5	27	38	41	39	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRTRTGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACCCCTTGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASNPLTGNTEAFF	In	VDJ	4	112	0.011221320508967037	0.013317479191438763	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	4	1	7	0	27	37	-1	44	50			01,02										Vb 17	CASNPLTGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGACAGGGCGAGGAGCTTTCTTTGGACAA	CASSIGTGRGAFF	In	VDJ	5	152	0.015228934976455265	0.01807372175980975	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	10	1	5	27	41	51	42	56			01,02										Vb 17	CASSIGTGRGAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAACTAGCGGGAGTTTTAATGAGCAGTTCTTCGGGCCA	CASSTTSGSFNEQFF	In	VDJ	5	160	0.01603045786995291	0.019024970273483946	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	3	2	7	2	4	27	40	53	42	57			01,02										Vb 17	CASSTTSGSFNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATGACTAGCGGGGGGGCAGATACGCAGTATTTTGGCCCA	CASSMTSGGADTQYF	In	VDJ	15	461	0.04618775673780182	0.054815695600475625	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	0	4	3	0	27	38	-1	41	55			01,02										Vb 17	CASSMTSGGADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTCCCCAGGGTCCGGACACTGAAGTTTTCTTTGGACAA	CASSPQGPDTEVFF	In	VDJ	1	20	0.0020038072337441137	0.0023781212841854932	42	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	6	13	11	7	28	40	56	51	63			01,02											CASSPQGPDTEVFF+TCRBV06-04+TCRBJ01-01	TCRBV06-04	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCACCCCCCTAGCGGGGGCCCTGATGGATGAGCAGTTCTTCGGGCCA	CASSTPLAGALMDEQFF	In	VDJ	1	15	0.0015028554253080854	0.0017835909631391202	51	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	2	8	7	9	26	37	54	44	63														CASSTPLAGALMDEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTTAGGAGGGTGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	11	0.0011020939785592627		43	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	10	0	2	2	1	19	33	41	35	42														X+TCRBV07-07+TCRBJ01-05	TCRBV07-07*01	TCRBD02-01*02	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCGCTTCAGGGATCCGGGAGACCCAGTACTTCGGGCCA	CASSASGIRETQYF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	3	5	4	6	19	31	40	35	46														CASSASGIRETQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGGGGCCTCCCGAGAGACCCAGTACTTCGGGCCA	CASSLGASRETQYF	In	VDJ	1	17	0.0017032361486824968	0.0020214030915576696	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	8	0	4	0	6	19	-1	39	35	45														CASSLGASRETQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGTCTGGTTTTTTCCCGGAAAAACTATTTTTTGGCAGT	CSARDLSGFFPEKLFF	In	VDJ	1	9	9.017132551848512E-4	0.001070154577883472	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	3	9	17	24	0	26	40	-1	64	68		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLSGFFPEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGAGCCGGGCCAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRAGPTNTGELFF	In	VDJ	1	9	9.017132551848512E-4	0.001070154577883472	45	TCRBV12						TCRBJ02	TCRBJ02-02	01	6	8	0	0	4	3	22	33	41	37	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRAGPTNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGACCCTGGGGCAGGAGACCCAGTACTTCGGGCCA	CASSLTLGQETQYF	In	VDJ	1	10	0.0010019036168720569	0.0011890606420927466	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	7	0	5	6	2	26	40	51	46	53		TCRBV12-03,TCRBV12-04												CASSLTLGQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGAAACAGGGAGGCCCTATGGCTACACCTTCGGTTCG	CASSQDETGRPYGYTF	In	VDJ	1	10	0.0010019036168720569	0.0011890606420927466	48	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	3	3	4	4	5	26	43	53	47	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDETGRPYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGCGGGGGGGAGACCCAGTACTTCGGGCCA	CSARDSGGETQYF	In	VDJ	1	10	0.0010019036168720569	0.0011890606420927466	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	1	5	0	0	26	-1	-1	40	50		TCRBV20-01,TCRBV20-or09_02												CSARDSGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGGGGGCAAGCTATGGCTACACCTTCGGTTCG	CSARDQGASYGYTF	In	VDJ	1	10	0.0010019036168720569	0.0011890606420927466	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	0	4	1	3	26	40	49	41	52		TCRBV20-01,TCRBV20-or09_02												CSARDQGASYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCCGCTCCCTGGAGGCTTTCTTTGGACAA	CSAARSLEAFF	In	VDJ	1	10	0.0010019036168720569	0.0011890606420927466	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	2	11	11	0	26	35	-1	46	50		TCRBV20-01,TCRBV20-or09_02												CSAARSLEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCAGGGGACAGGGGGGACTGAGGGCTACACCTTCGGTTCG	CATSDQGTGGTEGYTF	In	VDJ	1	10	0.0010019036168720569	0.0011890606420927466	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	1	8	3	7	24	39	53	42	60		TCRBV24-01,TCRBV24-or09_02												CATSDQGTGGTEGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGTGAACACGGCAGCAGAAAAGCTTTCTTTGGACAA	CASSEHGSRKAFF	In	VDJ	1	10	0.0010019036168720569	0.0011890606420927466	39	unresolved						TCRBJ01	TCRBJ01-01	01	3	3	6	9	0	11	23	-1	40	37	51	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEHGSRKAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGGCCTAATAGCGGGGGCGTCTACCAAGAGACCCAGTACTTCGGGCCA	CASRPNSGGVYQETQYF	In	VDJ	1	11	0.0011020939785592627	0.0013079667063020215	51				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	5	2	0	6	5	24	35	50	41	55	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASRPNSGGVYQETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGCAATCAGGAGATAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	11	0.0011020939785592627		46	TCRBV03						TCRBJ02	TCRBJ02-05	01	0	4	4	4	5	4	26	43	52	48	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGCGAGGGGATTGAGTATGGCTACACCTTCGGTTCG	CSAREGIEYGYTF	In	VDJ	1	11	0.0011020939785592627	0.0013079667063020215	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	5	2	5	5	6	26	34	44	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREGIEYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCTTAGGAAGAATTGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGRIGNTGELFF	In	VDJ	1	11	0.0011020939785592627	0.0013079667063020215	48	TCRBV12						TCRBJ02	TCRBJ02-02	01	1	1	8	2	8	0	22	38	-1	46	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRIGNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGCCACTACAATGAGCAGTTCTTCGGGCCA	CASSLGHYNEQFF	In	VDJ	1	12	0.0012022843402464682	0.001426872770511296	39	TCRBV12						TCRBJ02	TCRBJ02-01	01	1	4	6	3	2	0	26	42	-1	44	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGHYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACTCGACGATCGGGACAGCAAGAGACCCAGTACTTCGGGCCA	CATRRSGQQETQYF	In	VDJ	1	12	0.0012022843402464682	0.001426872770511296	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	0	5	2	10	0	24	31	-1	41	48	TCRBV06,TCRBV10													CATRRSGQQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGGACAGGGCGGTTTTGGGACACTGAAGCTTTCTTTGGACAA	CSARRTGRFWDTEAFF	In	VDJ	1	12	0.0012022843402464682	0.001426872770511296	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	3	3	1	10	26	38	47	39	57		TCRBV20-01,TCRBV20-or09_02												CSARRTGRFWDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTCCGAACAGGGTGTGGAAGAGACCCAGTACTTCGGGCCA	CASSSEQGVEETQYF	In	VDJ	1	12	0.0012022843402464682	0.001426872770511296	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	3	3	4	5	18	31	41	35	46	TCRBV07,TCRBV11													CASSSEQGVEETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCGGACCGCAGGGGCGCGATTCACCCCTCCACTTTGGGAAC	CASSGPQGRDSPLHF	In	VDJ	1	12	0.0012022843402464682	0.001426872770511296	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	2	8	6	4	22	34	46	40	50	TCRBV07,TCRBV11													CASSGPQGRDSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGTTCTCTTCTCATGCAAGATACGCAGTATTTTGGCCCA	CASSGSLLMQDTQYF	In	VDJ	1	13	0.001302474701933674	0.0015457788347205707	45	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	0	10	5	0	15	26	-1	40	38	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGSLLMQDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAGACAGGGATGAGACCCAGTACTTCGGGCCA	CSAIDRDETQYF	In	VDJ	1	13	0.001302474701933674	0.0015457788347205707	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	3	5	0	2	26	-1	45	40	47		TCRBV20-01,TCRBV20-or09_02												CSAIDRDETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAACCTTACATAACACTGAAGCTTTCTTTGGACAA	CSAPTLHNTEAFF	In	VDJ	1	13	0.001302474701933674	0.0015457788347205707	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	6	2	8	1	26	35	46	43	47		TCRBV20-01,TCRBV20-or09_02												CSAPTLHNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCTAGCGGGGGCGAAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	0.001302474701933674		44	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	4	2	5	0	5	19	-1	42	32	47		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCGGGTGGTCTGAGGGGAAACACTGAAGCTTTCTTTGGACAA	CSAAGGLRGNTEAFF	In	VDJ	1	14	0.0014026650636208796	0.0016646848989298453	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	5	2	2	13	1	26	34	52	47	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAAGGLRGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCTCTCCTGGGACAGGGGCAAACATTCAGTACTTCGGCGCC	CASSSPGTGANIQYF	In	VDJ	1	14	0.0014026650636208796	0.0016646848989298453	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	2	6	7	1	22	33	50	40	51	TCRBV12,TCRBV21													CASSSPGTGANIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGCGTCAGGGAATAATCAGCCCCAGCATTTTGGTGAT	CASSLASGNNQPQHF	In	VDJ	1	14	0.0014026650636208796	0.0016646848989298453	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	4	2	3	18	35	42	37	45	TCRBV07,TCRBV11													CASSLASGNNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGGACTCRGCCMTGTATCKCTGTGCCAGCAGCTCGACTAACGGGGACAATGAGCAGTTCTTCGGGCCA	CASSSTNGDNEQFF	In	VDJ	1	14	0.0014026650636208796	0.0016646848989298453	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	9	5	1	6	19	32	38	33	44	TCRBV05,TCRBV07					01,02								CASSSTNGDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCACTATTCGGGGGACAGGGGTATATTCACCCCTCCACTTTGGGAAC	CASTIRGTGVYSPLHF	In	VDJ	1	14	0.0014026650636208796	0.0016646848989298453	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	2	8	8	3	19	29	47	37	50	TCRBV05,TCRBV11													CASTIRGTGVYSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGTACTTCGGCCTAATGAAAAACTGTTTTTTGGCAGT	CASSLVLRPNEKLFF	In	VDJ	1	14	0.0014026650636208796	0.0016646848989298453	45	TCRBV05						TCRBJ01	TCRBJ01-04	01	2	9	0	3	8	0	19	33	-1	41	44		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVLRPNEKLFF+TCRBV05-X+TCRBJ01-04	TCRBV05		TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGAAGGATACGCAGTATTTTGGCCCA	CSARVKDTQYF	In	VDJ	1	15	0.0015028554253080854	0.0017835909631391202	33	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	2	8	6	1	2	26	39	42	40	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVKDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGACAGATACGCAGTATTTTGGCCCA	CSARSTDTQYF	In	VDJ	1	15	0.0015028554253080854	0.0017835909631391202	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	6	3	1	0	26	38	-1	39	41		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGGGGGGGTCAGATACGCAGTATTTTGGCCCA	CASSLAGGSDTQYF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	9	0	4	0	1	26	-1	50	43	51		TCRBV12-03,TCRBV12-04												CASSLAGGSDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
MRGGGACTYRGSCCTRTATYTCTGTGCCAGCAGCTTGGCCAACAGATTAGTCTCAAATTCACCCCTCCACTTTGGGAAC	CASSLANRLVSNSPLHF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	3	5	7	4	10	22	37	45	41	55	TCRBV05,TCRBV12													CASSLANRLVSNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTGTCCAGGGACTATGGCTACACCTTCGGTTCG	CASSVSRDYGYTF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	3	6	0	22	33	-1	39	44		TCRBV12-03,TCRBV12-04												CASSVSRDYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGTGACAGCGATGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSVTAMGNQPQHF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	5	2	1	6	24	37	43	38	49		TCRBV24-01,TCRBV24-or09_02												CASSVTAMGNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGGTCGAGGGCGTGACCCAGTACTTCGGGCCA	CASSLGVEGVTQYF	In	VDJ	1	17	0.0017032361486824968	0.0020214030915576696	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	11	0	7	5	3	26	42	52	47	55		TCRBV12-03,TCRBV12-04												CASSLGVEGVTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCAAAAGGGACACTGAAGCTTTCTTTGGACAA	CASSFKRDTEAFF	In	VDJ	1	17	0.0017032361486824968	0.0020214030915576696	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	5	3	3	4	0	26	40	-1	44	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFKRDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGACAATGGCTACACCTTCGGTTCG	CSARRDNGYTF	In	VDJ	1	17	0.0017032361486824968	0.0020214030915576696	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	6	6	1	0	26	38	-1	39	45		TCRBV20-01,TCRBV20-or09_02												CSARRDNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGGGGGAATCTAGTGGCTACACCTTCGGTTCG	CSARDLGESSGYTF	In	VDJ	1	17	0.0017032361486824968	0.0020214030915576696	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	6	1	7	3	7	26	40	48	43	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLGESSGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTCCAGCGGGGGGACCCGTACAATGAGCAGTTCTTCGGGCCA	CASSLQRGDPYNEQFF	In	VDJ	1	18	0.0018034265103697023	0.002140309155766944	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	1	4	4	5	18	30	43	34	48	TCRBV07,TCRBV11													CASSLQRGDPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCAGGRGACWCRGCMMKGTATYTCTGTGCCAGCAGCCTAGATTTTCGTGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLDFRASTDTQYF	In	VDJ	1	18	0.0018034265103697023	0.002140309155766944	48	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	5	4	8	0	0	11	24	-1	40	36	51	TCRBV11,TCRBV21			TCRBD01,TCRBD02										CASSLDFRASTDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGTTTCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARVSSSYNEQFF	In	VDJ	1	19	0.0019036168720569081	0.002259215219976219	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	0	0	7	26	-1	39	34	46		TCRBV20-01,TCRBV20-or09_02												CSARVSSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCGGCCMTKTATCTYTGYGCCAGCAGCTTTTACGGGCGGGGGGCCGCCTTGAACACTGAAGCTTTCTTTGGACAA	CASSFYGRGAALNTEAFF	In	VDJ	1	19	0.0019036168720569081	0.002259215219976219	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	7	1	0	6	6	19	33	47	39	53	TCRBV05,TCRBV11													CASSFYGRGAALNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACAAAGGGCTAGCGGAGACCCAGTACTTCGGGCCA	CSANKGLAETQYF	In	VDJ	1	20	0.0020038072337441137	0.0023781212841854932	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	4	6	5	8	0	26	36	-1	44	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSANKGLAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDPGSSYNEQFF	In	VDJ	1	20	0.0020038072337441137	0.0023781212841854932	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	8	3	0	2	2	26	40	47	42	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDPGSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGAAGACGCTAACTATGGCTACACCTTCGGTTCG	CSARDREDANYGYTF	In	VDJ	1	20	0.0020038072337441137	0.0023781212841854932	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	8	3	0	1	5	26	40	46	41	51		TCRBV20-01,TCRBV20-or09_02												CSARDREDANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTTACCCTAGTAAGCGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CSALTLVSGGQETQYF	In	VDJ	1	20	0.0020038072337441137	0.0023781212841854932	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	2	1	12	0	26	35	-1	47	55		TCRBV20-01,TCRBV20-or09_02												CSALTLVSGGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CACCWSCCARACAKCTKTGTACTTSTGTGCCAGCAGTTACGGGGGTTCAAACACCATATATTTTGGAGAG	CASSYGGSNTIYF	In	VDJ	1	20	0.0020038072337441137	0.0023781212841854932	39	unresolved			unresolved			TCRBJ01	TCRBJ01-03	01	13	8	2	6	11	3	25	28	45	39	48	TCRBV06,TCRBV22			TCRBD01,TCRBD02										CASSYGGSNTIYF+X+TCRBJ01-03	unresolved	unresolved	TCRBJ01-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGTCAGGCCAGCTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQASYSGANVLTF	In	VDJ	1	20	0.0020038072337441137	0.0023781212841854932	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	4	0	0	7	23	-1	39	35	46	TCRBV06,TCRBV10													CASSQASYSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCGGGGGACTAGCTGAGACCGAGACCCAGTACTTCGGGCCA	CASSGGLAETETQYF	In	VDJ	1	20	0.0020038072337441137	0.0023781212841854932	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	7	5	1	7	23	36	46	37	53	TCRBV02,TCRBV09					01,02								CASSGGLAETETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAGARGACTCRGCCCTSTATCTCTGYGCCAGCAGCCAAGAATATCAGGCAAACACTGAAGCTTTCTTTGGACAA	CASSQEYQANTEAFF	In	VDJ	1	21	0.0021039975954313195	0.002497027348394768	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	4	2	4	2	23	40	48	44	50	TCRBV04,TCRBV05													CASSQEYQANTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTCCCAGACATCTGTGTAYTTCTGYGCCAGCAGTGTCCCAGGGTCCTACGAGCAGTACGTCGGGCCG	CASSVPGSYEQYV	In	VDJ	1	22	0.0022041879571185253	0.002615933412604043	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	17	3	16	24	37	45	40	61	TCRBV06,TCRBV10													CASSVPGSYEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGGTCGGGTCTGGAAACACCATATATTTTGGAGAG	CSAQVGSGNTIYF	In	VDJ	1	22	0.0022041879571185253	0.002615933412604043	39	TCRBV20						TCRBJ01	TCRBJ01-03	01	6	4	4	1	1	5	26	34	39	35	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAQVGSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCCTCCCTACTGGTTACACCTTCGGTTCG	CSALLPTGYTF	In	VDJ	1	22	0.0022041879571185253	0.002615933412604043	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	3	10	11	9	3	26	35	47	44	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSALLPTGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGCCGACGGAACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSADGTTNEKLFF	In	VDJ	1	22	0.0022041879571185253	0.002615933412604043	45	unresolved						TCRBJ01	TCRBJ01-04	01	6	1	8	0	7	1	22	33	43	40	44	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSADGTTNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCGAGCGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPSGGNTGELFF	In	VDJ	1	23	0.002304378318805731	0.0027348394768133173	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	6	2	1	4	0	26	37	-1	41	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPSGGNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAATCCGGCGATGAACACTGAAACTTTCTTTGGACAA	CASSLNPAMNTETFF	In	VDJ	1	23	0.002304378318805731	0.0027348394768133173	45	TCRBV12						TCRBJ01	TCRBJ01-01	01	2	3	6	12	13	6	26	41	57	54	63		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNPAMNTETFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGACCAGAACACTGAAGCTTTCTTTGGACAA	CSADQNTEAFF	In	VDJ	1	23	0.002304378318805731	0.0027348394768133173	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	2	7	1	1	2	26	34	38	35	40		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSADQNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAAACAGGGCCCTCCAAGAGACCCAGTACTTCGGGCCA	CASSENRALQETQYF	In	VDJ	1	23	0.002304378318805731	0.0027348394768133173	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	1	4	4	22	34	44	38	48	TCRBV09,TCRBV12													CASSENRALQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTCCCGAAGGGGGCAAGGAGACCCAGTACTTCGGGCCA	CASSPEGGKETQYF	In	VDJ	1	23	0.002304378318805731	0.0027348394768133173	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	5	0	5	5	3	26	38	50	43	53	TCRBV06,TCRBV10													CASSPEGGKETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCCAAGTCATTTCATACATCATAATTCACCCCTCCATTTGGGAAC		Out	VDJ	1	24	0.0024045686804929365		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	6	22	15	18	26	40	58	55	76		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCCCGAGGTTAATCGGGGAGCTGTTTTTTGGAGAA	CASSPRLIGELFF	In	VDJ	1	24	0.0024045686804929365	0.002853745541022592	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	1	7	2	5	24	36	42	38	47	TCRBV12,TCRBV21													CASSPRLIGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTCGACAATAAAAATGAGCAGTTCTTCGGGCCA	CSARVDNKNEQFF	In	VDJ	1	25	0.0025047590421801423	0.002972651605231867	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	6	7	4	5	26	37	45	41	50		TCRBV20-01,TCRBV20-or09_02												CSARVDNKNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTCGGGACAGCCCAAGAGACCCAGTACTTCGGGCCA	CASSFGTAQETQYF	In	VDJ	1	25	0.0025047590421801423	0.002972651605231867	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	5	1	1	1	19	33	41	34	42		TCRBV05-06,TCRBV05-07												CASSFGTAQETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD01-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCACCGGGTCGGAACATATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	0.002805330127241759		46	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	4	5	4	8	24	39	47	43	55		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTTAACTACGCCCGGGAGGTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	28	0.002805330127241759		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	8	1	5	13	1	20	31	51	44	52	TCRBV07,TCRBV23													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAACAGGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASNRGAGELFF	In	VDJ	1	28	0.002805330127241759	0.0033293697978596906	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	3	1	6	0	1	23	-1	41	33	42	TCRBV02,TCRBV21													CASNRGAGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGTACGGCAGGGGGCACGAAACCAATCAGCCCCAGCATTTTGGTGAT	CSAREYGRGHETNQPQHF	In	VDJ	1	29	0.002905520488928965	0.0034482758620689655	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	0	3	6	7	26	40	54	46	61		TCRBV20-01,TCRBV20-or09_02												CSAREYGRGHETNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CRRRRGACTCAGCCSTGTATCTCTRCACCAGCAGGTTATTCGGTTTGTGCACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC	XTSRLFGLCTKRANVLTF	In	VDJ	1	29	0.002905520488928965	0.0034482758620689655	54	unresolved			unresolved			TCRBJ02	TCRBJ02-06	01	10	4	4	5	4	22	22	26	34	30	56	TCRBV04,TCRBV17			TCRBD01,TCRBD02										XTSRLFGLCTKRANVLTF+X+TCRBJ02-06	unresolved	unresolved	TCRBJ02-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGGCTGTATCCCATTTCATACACATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	30	0.003005710850616171		55	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	6	5	19	1	26	38	60	57	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCGGGACAGGGGACCGCAGCCCCAGCATTTTGGTGAT	CASSRDRGPQPQHF	In	VDJ	1	33	0.0033062819356777877	0.003923900118906064	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	2	7	1	4	24	36	47	37	51	TCRBV06,TCRBV10													CASSRDRGPQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGAACCGGGACAGGGGACTATGGCTACACCTTCGGTTCG	CASSQGTGTGDYGYTF	In	VDJ	1	33	0.0033062819356777877	0.003923900118906064	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	3	7	0	26	40	-1	47	57		TCRBV03-01,TCRBV03-02												CASSQGTGTGDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTGAGAGGGGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSLRGGPTDTQYF	In	VDJ	1	33	0.0033062819356777877	0.003923900118906064	45	unresolved						TCRBJ02	TCRBJ02-03	01	4	5	1	2	4	3	22	35	45	39	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGGPTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGCAGGGGGCGTTACACCTTCGGTTCG		Out	VDJ	1	34	0.0034064722973649935		37	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	0	11	4	2	26	40	52	44	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCAGGGGTATAGGCAATCAGCCCCAGCATTTTGGTGAT	CSARGRGIGNQPQHF	In	VDJ	1	34	0.0034064722973649935	0.004042806183115339	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	2	3	5	26	37	46	40	51		TCRBV20-01,TCRBV20-or09_02												CSARGRGIGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAGGGAAAGATACGCAGTATTTTGGCCCA	CSATGKDTQYF	In	VDJ	1	36	0.0036068530207394047	0.004280618311533888	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	5	0	2	26	-1	41	36	43		TCRBV20-01,TCRBV20-or09_02												CSATGKDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAGGGACAGGGGGCGCCGATGGCTACACCTTCGGTTCG	CATSEGTGGADGYTF	In	VDJ	1	36	0.0036068530207394047	0.004280618311533888	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	0	6	1	4	24	38	51	39	55		TCRBV24-01,TCRBV24-or09_02												CATSEGTGGADGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTGGGGGGCATGAACACTGAAGCTTTCTTTGGACAA	CASSVGGMNTEAFF	In	VDJ	1	38	0.0038072337441138163	0.004518430439952438	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	6	0	0	4	1	26	37	47	41	48		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGGMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAATCGTCGGTCTATAATGAGCAGTTCTTCGGGCCA	CASSESSVYNEQFF	In	VDJ	1	39	0.003907424105801022	0.004637336504161712	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	9	7	12	1	23	34	49	46	50	TCRBV09,TCRBV12					01,02								CASSESSVYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCAGGGGACTAGCGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	40	0.0040076144674882274		46	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	5	1	5	0	26	37	-1	42	53		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCAGGGGGGAGCAGTTCTTCGGGCCA	CASSRRGEQFF	In	VDJ	1	41	0.004107804829175434	0.004875148632580262	33	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	1	10	1	0	26	39	-1	40	47		TCRBV03-01,TCRBV03-02												CASSRRGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTACTCTCTAGCGGGGGTGTTCGAGCAGTACGTCGGGCCG		Out	VDJ	1	41	0.004107804829175434		46	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	17	6	15	22	35	51	41	66	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGGAAGCGGGGGTGTCAGAGACCCAGTACTTCGGGCCA	CASSLEAGVSETQYF	In	VDJ	1	42	0.004207995190862639	0.004994054696789536	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	6	2	4	3	4	18	32	43	35	47	TCRBV07,TCRBV11													CASSLEAGVSETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTATAGAGCCATTTCAGGCTTGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	44	0.004408375914237051		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	4	5	14	4	26	38	56	52	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTAGTGGGGGAGGGAAACATTCAGTACTTCGGCGCC	CASSLVGEGNIQYF	In	VDJ	1	44	0.004408375914237051	0.005231866825208086	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	9	0	6	8	0	20	31	-1	39	46	TCRBV11,TCRBV23													CASSLVGEGNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTAGCTGGACAGGGCAAAGGCTACACCTTCGGTTCG	CASSLAGQGKGYTF	In	VDJ	1	44	0.004408375914237051	0.005231866825208086	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	8	1	4	19	36	45	37	49	TCRBV05,TCRBV11													CASSLAGQGKGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCGCTAGACAGGGGATGAACACTGAAGCTTTCTTTGGACAA	CAARQGMNTEAFF	In	VDJ	1	45	0.004508566275924256	0.00535077288941736	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	2	2	0	4	1	24	30	42	34	43	TCRBV09,TCRBV21													CAARQGMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGACCTCGGAACAGGGCGGGCTTTCTTTGGACAA		Out	VDJ	2	47	0.0047089469992986676		40	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	11	9	3	26	39	54	48	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAGACAGGCCTACCAAATGAAAAACTGTTTTTTGGCAGT	CSASETGLPNEKLFF	In	VDJ	2	49	0.004909327722673079	0.005826397146254459	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	4	5	3	7	26	37	46	40	53		TCRBV20-01,TCRBV20-or09_02												CSASETGLPNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCGGGACAGGCATGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGTGMSNTGELFF	In	VDJ	2	50	0.0050095180843602845	0.005945303210463734	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	4	0	2	5	18	31	41	33	46	TCRBV07,TCRBV11													CASSSGTGMSNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCGTAAGACTAGCGGGGGGGCTCGAGGCAGATACGCAGTATTTTGGCCCA	CASSVRLAGGLEADTQYF	In	VDJ	2	52	0.005209898807734696	0.006183115338882283	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	2	0	4	4	7	23	35	53	39	60	TCRBV01,TCRBV04													CASSVRLAGGLEADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTACGACGCGCCCGCACAGATACGCAGTATTTTGGCCCA	CASSLRRARTDTQYF	In	VDJ	2	53	0.0053100891694219015	0.006302021403091558	45	unresolved						TCRBJ02	TCRBJ02-03	01	2	2	7	1	1	6	18	33	37	34	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRRARTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGCCGGGGAAACTGAAGCTTTCTTTGGACAA	CSARAGETEAFF	In	VDJ	2	54	0.005410279531109108	0.0064209274673008325	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	4	3	5	0	8	26	-1	39	34	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARAGETEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGCAGAAGAACACTGAAGCTTTCTTTGGACAA	CSARDPQKNTEAFF	In	VDJ	2	56	0.005610660254483518	0.006658739595719381	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	5	1	4	2	26	40	47	44	49		TCRBV20-01,TCRBV20-or09_02												CSARDPQKNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAAAACAGGGGTGGAAAAACTGTTTTTTGGCAGT	CASSEKTGVEKLFF	In	VDJ	2	61	0.006111612062919547	0.007253269916765755	42	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	2	8	3	2	23	38	48	41	50		TCRBV06-01,TCRBV06-08												CASSEKTGVEKLFF+TCRBV06-X+TCRBJ01-04	TCRBV06	TCRBD01-01*01	TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCRGCYRTGTATYKYTGTGCCAGCAGCTTAACGTCTACGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLTSTGTGELFF	In	VDJ	2	66	0.0066125638713555755	0.007847800237812128	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	3	5	7	0	18	33	-1	40	45	TCRBV07,TCRBV12													CASSLTSTGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGTCCCTTGAAGCTTTCTTTGGACAA	CSARRSLEAFF	In	VDJ	2	69	0.0069131349564171924	0.008204518430439952	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	5	4	7	0	5	26	-1	41	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRSLEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGGGCCCCATAACTATGGCTACACCTTCGGTTCG	CSARGTGPHNYGYTF	In	VDJ	2	69	0.0069131349564171924	0.008204518430439952	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	3	1	0	5	26	-1	47	39	52		TCRBV20-01,TCRBV20-or09_02												CSARGTGPHNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCTGTGAGAGGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSARSVRGPNTGELFF	In	VDJ	3	78	0.007814848211602044	0.009274673008323424	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	11	0	0	8	1	26	37	50	45	51		TCRBV20-01,TCRBV20-or09_02												CSARSVRGPNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCACCGGGGGTCAGGGAATAGTAGGGGAGACCCAGTACTTCGGGCCA	CASTGGQGIVGETQYF	In	VDJ	4	120	0.012022843402464683	0.014268727705112961	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	10	8	2	5	4	16	24	31	41	35	57	TCRBV12,TCRBV21													CASTGGQGIVGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTGCGCTCACCCAGAACAACAATGAGCAGTTCTTCGGGCCA	CSARDLALTQNNNEQFF	In	VDJ	4	121	0.01212303376415189	0.014387633769322235	51	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	3	6	5	17	0	26	40	-1	57	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLALTQNNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATCGTAGAGACAGGGGGCTCTATGGCTACACCTTCGGTTCG	XASSQDRRDRGLYGYTF	In	VDJ	1	10	0.0010019036168720569	0.0011890606420927466	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	0	4	7	1	22	39	56	46	57													Vb 7.1	XASSQDRRDRGLYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGGCCATACTAGCAGATACGCAGTATTTTGGCCCA	CASSQAILADTQYF	In	VDJ	6	173	0.017332932571886586	0.020570749108204518	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	3	8	4	6	0	23	37	-1	43	48						01,02							Vb 7.1	CASSQAILADTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTACGCTTCGGGACGGGAGACGACTTATAACACTGAAGCTTTCTTTGGACAA	CASSYASGRETTYNTEAFF	In	VDJ	1	22	0.0022041879571185253	0.002615933412604043	57	TCRBV06	TCRBV06-09	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	2	2	10	9	24	38	54	48	63													Vb 13.1	CASSYASGRETTYNTEAFF+TCRBV06-09+TCRBJ01-01	TCRBV06-09*01	TCRBD02-01*02	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATGGGAGACAGGAGTCCGAGATCACCCCTCCACTTTGGGAAC		Out	VDJ	1	12	0.0012022843402464682		49	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	4	10	5	9	25	39	50	44	59													Vb 4	X+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCTTCGCGCTAGCCTAGGGTCCAATGAGCAGTTCTTCGGGCCA	CSVEDLRASLGSNEQFF	In	VDJ	1	13	0.001302474701933674	0.0015457788347205707	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	7	6	8	8	25	39	52	47	60						01,02							Vb 4	CSVEDLRASLGSNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGGGACGCAATCTAACTATGGCTACACCTTCGGTTCG	CSVGGTQSNYGYTF	In	VDJ	1	18	0.0018034265103697023	0.002140309155766944	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	4	0	7	0	2	5	25	35	42	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGGTQSNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAACTGGACATTAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVQLDINSGANVLTF	In	VDJ	1	19	0.0019036168720569081	0.002259215219976219	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	0	5	4	25	34	44	39	48													Vb 4	CSVQLDINSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGCCGGGACAGGAACTGAAGCTTTCTTTGGACAA	CSVGAGTGTEAFF	In	VDJ	1	22	0.0022041879571185253	0.002615933412604043	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	4	5	5	1	25	35	48	40	49													Vb 4	CSVGAGTGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATTCGGGCCTGGGGACGTGCAAGAGACCCAGTACTTCGGGCCA	CSVEFGPGDVQETQYF	In	VDJ	1	24	0.0024045686804929365	0.002853745541022592	48	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	2	0	7	2	10	3	25	37	52	47	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEFGPGDVQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGCTAGGGGATCAAAACATTCAGTACTTCGGCGCC	CSVGLGDQNIQYF	In	VDJ	1	42	0.004207995190862639	0.004994054696789536	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	5	2	5	4	3	25	35	44	39	47													Vb 4	CSVGLGDQNIQYF+TCRBV29-01+TCRBJ02-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACAGGGGGCACTAATGAAAAACTGTTTTTTGGCAGT	CSVGTGGTNEKLFF	In	VDJ	3	80	0.008015228934976455	0.009512485136741973	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	0	2	0	0	25	-1	-1	35	46													Vb 4	CSVGTGGTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTCGCAGCGCAATCTCGGAAAGACCTATGGCTACACCTTCGGTTCG	CASSSQRNLGKTYGYTF	In	VDJ	1	14	0.0014026650636208796	0.0016646848989298453	51	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	6	6	4	3	15	18	31	38	34	53		TCRBV07-02,TCRBV07-08				01,02								CASSSQRNLGKTYGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTTCGGGGGAGGTAATGAGCAGTTCTTCGGGCCA	CASSFGGGNEQFF	In	VDJ	1	19	0.0019036168720569081	0.002259215219976219	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	2	7	1	4	23	36	43	37	47		TCRBV06-07,TCRBV06-08				01,02								CASSFGGGNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSYSGSTDTQYF	In	VDJ	1	19	0.0019036168720569081	0.002259215219976219	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-03	01	0	6	2	0	0	0	26	-1	-1	43	47		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGSTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGGGGGGGACAGCGAACACTGAAGCTTTCTTTGGACAA	CASRGGTANTEAFF	In	VDJ	1	24	0.0024045686804929365	0.002853745541022592	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	6	0	5	1	4	1	23	34	45	38	46		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGGTANTEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCCATCGACTAGCGGGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	27	0.002705139765554554		47	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	2	3	3	4	0	19	31	-1	35	46		TCRBV07-05,TCRBV07-06												X+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGCGCTCCGGACAGTAAGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSEALRTVRLNTEAFF	In	VDJ	1	32	0.003206091573990582	0.0038049940546967895	54	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	0	10	6	26	38	54	48	60		TCRBV06-01,TCRBV06-07												CASSEALRTVRLNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGCTTTTCGGGACAGGGGGCGTACTATGGCTACACCTTCGGTTCG	CASSFSGQGAYYGYTF	In	VDJ	1	36	0.0036068530207394047	0.004280618311533888	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	0	3	6	2	23	34	52	40	54		TCRBV06-04,TCRBV06-08												CASSFSGQGAYYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCATGCCAACGGTGAATTCACCCCTCCACTTTGGGAAC	CASMPTVNSPLHF	In	VDJ	1	37	0.0037070433824266105	0.004399524375743163	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	8	5	7	6	2	23	33	42	39	44		TCRBV06-07,TCRBV06-08				01,02								CASMPTVNSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCCGACAGGAGCCGAACACTGAAGCTTTCTTTGGACAA	CASRQEPNTEAFF	In	VDJ	1	40	0.0040076144674882274	0.0047562425683709865	39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	4	1	1	4	26	35	42	36	46		TCRBV10-01,TCRBV10-02												CASRQEPNTEAFF+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGAGGGACCAGCTCAGATACGCAGTATTTTGGCCCA	CATSRDGGTSSDTQYF	In	VDJ	2	75	0.007514277126540427	0.0089179548156956	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	0	4	1	7	18	35	42	36	49														CATSRDGGTSSDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATATAGGTCTTGAGGTGAACCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	6	198	0.019837691614066726		56	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	11	1	1	10	6	18	35	49	45	55														X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGTAGGTTGGACAAGTCCCGGGTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLA*VGQVPGNSNQPQHF	Stop	VDJ	1	19	0.0019036168720569081		63	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	6	0	7	12	18	35	47	42	59														CASSLA*VGQVPGNSNQPQHF+TCRBV07-02+TCRBJ01-05	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTACAAGGGGACAGCACAGATACGCAGTATTTTGGCCCA	CASSLQGDSTDTQYF	In	VDJ	1	12	0.0012022843402464682	0.001426872770511296	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	2	0	7	0	4	0	18	33	-1	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQGDSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACGGGGTTGGAGACCCAGTACTTCGGGCCA	CASSLGTGLETQYF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	3	5	3	3	18	34	42	37	45														CASSLGTGLETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGCGGAGCGGGGGGGCCGTAGAGACCCAGTACTTCGGGCCA	CASSRRSGGAVETQYF	In	VDJ	1	17	0.0017032361486824968	0.0020214030915576696	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	0	4	6	4	18	30	46	36	50														CASSRRSGGAVETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGACAGGAGCCCTTTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	19	0.0019036168720569081		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	4	17	1	20	18	30	37	31	57														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACAACATCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGTTSNTGELFF	In	VDJ	1	19	0.0019036168720569081	0.002259215219976219	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	6	0	2	4	18	31	39	33	43														CASSSGTTSNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGTGCGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLVRGSTDTQYF	In	VDJ	1	20	0.0020038072337441137	0.0023781212841854932	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	2	0	1	0	18	34	-1	35	42														CASSLVRGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTTAAGACAGGCGGGTGAAGCTTTCTTTGGACAA	CASSPLRQAGEAFF	In	VDJ	1	21	0.0021039975954313195	0.002497027348394768	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	7	7	4	18	30	43	37	47														CASSPLRQAGEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAATACAGGGGCATTGGGCTATGGCTACACCTTCGGTTCG	CASSNTGALGYGYTF	In	VDJ	1	24	0.0024045686804929365	0.002853745541022592	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	4	3	7	18	30	40	33	47														CASSNTGALGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGTTCGAGGACTAGCGGGGGAAAAGACCCAGTACTTCGGGCCA	CASVRGLAGEKTQYF	In	VDJ	1	30	0.003005710850616171	0.0035671819262782403	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	1	2	6	6	3	18	27	46	33	49														CASVRGLAGEKTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAATCGCAGGGCTGGGATGACCGGGGAGCTGTTTTTTGGAGAA	CASSLNRRAGMTGELFF	In	VDJ	1	32	0.003206091573990582	0.0038049940546967895	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	3	5	5	8	18	33	43	38	51														CASSLNRRAGMTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCTAGGGGGGGGCGGTAATTCACCCCTCCACTTTGGGAAC	CASSSLGGGGNSPLHF	In	VDJ	1	36	0.0036068530207394047	0.004280618311533888	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	4	9	0	6	5	4	18	31	43	36	47														CASSSLGGGGNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTATGGAGGGAGCGATGAGCAGTTCTTCGGGCCA	CASSSYGGSDEQFF	In	VDJ	1	44	0.004408375914237051	0.005231866825208086	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	10	0	8	5	4	18	31	42	36	46														CASSSYGGSDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGCGAAAGTTACCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	56	0.005610660254483518		55	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	15	5	18	30	48	45	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCTTGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSLSWENTEAFF	In	VDJ	3	79	0.00791503857328925	0.0093935790725327	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	2	0	8	1	4	0	18	33	-1	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSWENTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTGGACAGGGGGCTTAATTGTCGAAAAACTGTTTTTTGGCAGT	CASSFWTGGLIVEKLFF	In	VDJ	3	105	0.010519987977156597	0.01248513674197384	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	0	8	2	9	18	32	45	34	54														CASSFWTGGLIVEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGAATCCTGATGGCACAGATACGCAGTATTTTGGCCCA	CASSSNPDGTDTQYF	In	VDJ	6	174	0.01743312293357379	0.020689655172413793	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	4	2	8	1	1	9	18	31	34	32	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSNPDGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCTAGGTTTGCCCCAGCATTTTGGTGAT	CASGLGLPQHF	In	VDJ	1	9	9.017132551848512E-4	0.001070154577883472	33	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	4	8	9	1	4	26	37	42	38	46						01,02								CASGLGLPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD02-01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCAGAAGGGCGGCAGCCCCAGCATTTTGGTGAT	CASGPEGRQPQHF	In	VDJ	1	9	9.017132551848512E-4	0.001070154577883472	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	5	5	3	7	5	3	26	38	47	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPEGRQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCTCTGGTGGGGGCTCAAAGACCCAGTACTTCGGGCCA	CASSGGGSKTQYF	In	VDJ	1	12	0.0012022843402464682	0.001426872770511296	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	12	6	0	6	10	4	26	31	47	41	51														CASSGGGSKTQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACGGGACAGCGCTATGGCTACACCTTCGGTTCG	CASTGQRYGYTF	In	VDJ	1	15	0.0015028554253080854	0.0017835909631391202	36	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	12	0	5	4	6	2	26	31	44	37	46														CASTGQRYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTAAGCTGGACAGGGCGAAATGGCTACACCTTCGGTTCG	CASSLSWTGRNGYTF	In	VDJ	1	9	9.017132551848512E-4	0.001070154577883472	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	6	8	4	20	31	47	39	51														CASSLSWTGRNGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCTTCAGGGGAGTAACTATGGCTACACCTTCGGTTCG	CASSLQGSNYGYTF	In	VDJ	1	12	0.0012022843402464682	0.001426872770511296	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	1	4	2	20	31	41	35	43														CASSLQGSNYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGTCAGACAGGTATCGCACTGAAGCTTTCTTTGGACAA	CASSQSDRYRTEAFF	In	VDJ	7	214	0.02144073740106202	0.02544589774078478	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	4	7	5	20	31	44	38	49														CASSQSDRYRTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAATCTGCCAGATTACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	9	9.017132551848512E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	5	3	6	3	23	37	46	43	49														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGGACGGGCGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSWGRASNQPQHF	In	VDJ	1	9	9.017132551848512E-4	0.001070154577883472	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	4	0	7	1	1	5	23	36	42	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGRASNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATGGGCCTATGGGGACTAGCGGGGAGCAATTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	0.001603045786995291		61	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	4	12	6	20	32	57	44	63														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCAACGCGGGGGGCCAGGGAAATGAGCAGTTCTTCGGGCCA	CASSYSNAGGQGNEQFF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	1	7	4	7	23	40	52	44	59														CASSYSNAGGQGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCAGGGCGCTGAAGCTTTCTTTGGACAA	CASSFQGAEAFF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	6	2	2	23	36	43	38	45														CASSFQGAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCCCAACAGGGAAAAGGTGGTGGCTACACCTTCGGTTCG	CAAQQGKGGGYTF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	3	3	7	5	9	23	29	40	34	49														CAAQQGKGGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAACAACTCGAGATACGCAGTATTTTGGCCCA	CASKTTRDTQYF	In	VDJ	1	25	0.0025047590421801423	0.002972651605231867	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	7	3	6	5	2	5	23	33	38	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKTTRDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCTCGGGAGGGTACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	0.0025047590421801423		37	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	8	0	5	3	1	23	33	44	36	45														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACTAGCGGCCACACAGATACGCAGTATTTTGGCCCA	CASSYSTSGHTDTQYF	In	VDJ	1	29	0.002905520488928965	0.0034482758620689655	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	5	2	0	3	23	-1	49	40	52						01,02								CASSYSTSGHTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGCAAGTCCTATGCATAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	31	0.0031059012123033766		55	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	4	9	0	5	0	19	23	-1	39	36	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGTGTGGGAGGGACGGCAATCACCGGGGAGCTGTTTTTTGGAGAA	CAISGVGGTAITGELFF	In	VDJ	1	31	0.0031059012123033766	0.0036860879904875147	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	0	4	5	8	23	35	47	40	55														CAISGVGGTAITGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCAACGGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASATGATNEKLFF	In	VDJ	1	35	0.0035066626590521993	0.004161712247324614	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	8	8	2	0	4	0	23	32	-1	36	42														CASATGATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGCGAGGGATCTCTGGAAACACCATATATTTTGGAGAG	CASSRRGISGNTIYF	In	VDJ	1	37	0.0037070433824266105	0.004399524375743163	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	11	0	0	4	2	23	35	44	39	46														CASSRRGISGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGAGCGGGGGGGATACGAGGCACAGATACGCAGTATTTTGGCCCA	CASSYRAGGIRGTDTQYF	In	VDJ	1	41	0.004107804829175434	0.004875148632580262	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	0	1	2	7	23	38	50	40	57														CASSYRAGGIRGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATTCGAAGCGGGGCTTCGAACACTGAAGCTTTCTTTGGACAA	CAIRSGASNTEAFF	In	VDJ	1	45	0.004508566275924256	0.00535077288941736	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	10	6	3	1	5	4	23	30	42	35	46														CAIRSGASNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGGAGGGACCTTCGTAAGGCGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	52	0.005209898807734696		41	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	9	0	7	5	2	11	23	31	38	33	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATCCCGAGAAGGTTCACCCCTCCACTTTGGGAAC	CASRSREGSPLHF	In	VDJ	2	65	0.00651237350966837	0.0077288941736028535	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	6	5	4	9	9	0	23	34	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSREGSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGTGACAGGGGGTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYRDRGFSGANVLTF	In	VDJ	2	73	0.007313896403166016	0.008680142687277051	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	2	1	0	3	2	23	38	50	41	52														CASSYRDRGFSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTTGGGGTGAGATGAGCARTTCTTCGGGCCA	CASTLG*DEQFF	Stop	VDJ	2	76	0.0076144674882276326		36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	7	6	2	16	4	12	23	33	41	37	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLG*DEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAATCGGGGGGCAGAGCGARAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	76	0.0076144674882276326		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	1	8	2	8	23	37	46	39	54														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-04*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATACAGGGTTTTGGAGGAAACACCATATATTTTGGAGAG		Out	VDJ	3	82	0.008215609658350867		44	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	2	5	3	4	0	7	23	-1	42	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACTTACAGGGGTTAGGAGGGCAGCCCCAGCATTTTGGTGAT	CASNLQGLGGQPQHF	In	VDJ	4	136	0.013625889189459974	0.016171224732461357	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	2	7	4	9	23	33	44	37	53														CASNLQGLGGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCTACGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPYENTGELFF	In	VDJ	8	244	0.024446448251678188	0.02901307966706302	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	9	1	2	3	23	35	40	37	43						01,02								CASSPYENTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTACACTAGCGGGGGGAATCCAAGAGACCCAGTACTTCGGGCCA	CASSTLAGGIQETQYF	In	VDJ	1	16	0.001603045786995291	0.0019024970273483948	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	3	1	1	3	3	24	35	50	38	53													Vb 18	CASSTLAGGIQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCCTTAGCGGGGGTTAACAATGAGCAGTTCTTCGGGCCA	CASSALAGVNNEQFF	In	VDJ	1	19	0.0019036168720569081	0.002259215219976219	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	2	5	4	3	24	36	49	40	52													Vb 18	CASSALAGVNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAGACAGCTAATCAGCCCCAGCATTTTGGTGAT	CASSPETANQPQHF	In	VDJ	1	31	0.0031059012123033766	0.0036860879904875147	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	5	4	3	2	24	38	46	41	48													Vb 18	CASSPETANQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAATGGCGGGGGCTGCTGGAAACACCATATATTTTGGAGAG	CASSPTMAGAAGNTIYF	In	VDJ	1	36	0.0036068530207394047	0.004280618311533888	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	3	7	2	2	7	3	24	38	52	45	55													Vb 18	CASSPTMAGAAGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-03*01	4425A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				386	325	49	11	0	259	219	34	6	0	9981	8410	1280	291	0	0.0819082335	7.13796806	0.0753372163	7.41284418				4758	0.0655366331	0.0548156947	0.0461877584	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:47	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8419688889680387	MSKCC- Snyder- P01-02		312.0	
